These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22820159)

  • 21. CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia.
    Hosen N; Park CY; Tatsumi N; Oji Y; Sugiyama H; Gramatzki M; Krensky AM; Weissman IL
    Proc Natl Acad Sci U S A; 2007 Jun; 104(26):11008-13. PubMed ID: 17576927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myeloid malignancies and the microenvironment.
    Korn C; Méndez-Ferrer S
    Blood; 2017 Feb; 129(7):811-822. PubMed ID: 28064238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute promyelocytic leukemia: where does it stem from?
    Grimwade D; Enver T
    Leukemia; 2004 Mar; 18(3):375-84. PubMed ID: 14737069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mixed lineage leukemia translocations and a leukemia stem cell program.
    Faber J; Armstrong SA
    Cancer Res; 2007 Sep; 67(18):8425-8. PubMed ID: 17875678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of Microenvironment in Resistance to Therapy in AML.
    Tabe Y; Konopleva M
    Curr Hematol Malig Rep; 2015 Jun; 10(2):96-103. PubMed ID: 25921386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human acute myeloid leukemia stem cells.
    Hope KJ; Jin L; Dick JE
    Arch Med Res; 2003; 34(6):507-14. PubMed ID: 14734090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and targeting leukemia stem cells: The path to the cure for acute myeloid leukemia.
    Zhou J; Chng WJ
    World J Stem Cells; 2014 Sep; 6(4):473-84. PubMed ID: 25258669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell division patterns in acute myeloid leukemia stem-like cells determine clinical course: a model to predict patient survival.
    Stiehl T; Baran N; Ho AD; Marciniak-Czochra A
    Cancer Res; 2015 Mar; 75(6):940-9. PubMed ID: 25614516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up.
    Boyer T; Gonzales F; Plesa A; Peyrouze P; Barthelemy A; Guihard S; Quesnel B; Roumier C; Preudhomme C; Cheok M
    J Vis Exp; 2018 Mar; (133):. PubMed ID: 29630051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Redistribution, homing and organ-invasion of neoplastic stem cells in myeloid neoplasms.
    Valent P; Sadovnik I; Eisenwort G; Herrmann H; Bauer K; Mueller N; Sperr WR; Wicklein D; Schumacher U
    Semin Cancer Biol; 2020 Feb; 60():191-201. PubMed ID: 31408723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of murine and human acute myeloid leukemia stem cells.
    Deshpande AJ; Ahmed F; Buske C
    Methods Mol Biol; 2009; 568():21-35. PubMed ID: 19582419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concise review: preleukemic stem cells: molecular biology and clinical implications of the precursors to leukemia stem cells.
    Pandolfi A; Barreyro L; Steidl U
    Stem Cells Transl Med; 2013 Feb; 2(2):143-50. PubMed ID: 23349328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic and epigenetic alterations that drive leukemic stem cell self-renewal.
    van den Boom V; Horton SJ; Schuringa JJ
    J Stem Cells; 2012; 7(3):155-79. PubMed ID: 23619382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Normal and leukemic stem cell niches: insights and therapeutic opportunities.
    Schepers K; Campbell TB; Passegué E
    Cell Stem Cell; 2015 Mar; 16(3):254-67. PubMed ID: 25748932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant marker expression patterns on the CD34+CD38- stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission.
    van Rhenen A; Moshaver B; Kelder A; Feller N; Nieuwint AW; Zweegman S; Ossenkoppele GJ; Schuurhuis GJ
    Leukemia; 2007 Aug; 21(8):1700-7. PubMed ID: 17525725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors.
    Huntly BJ; Shigematsu H; Deguchi K; Lee BH; Mizuno S; Duclos N; Rowan R; Amaral S; Curley D; Williams IR; Akashi K; Gilliland DG
    Cancer Cell; 2004 Dec; 6(6):587-96. PubMed ID: 15607963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic myeloid leukemia stem cells.
    Kavalerchik E; Goff D; Jamieson CH
    J Clin Oncol; 2008 Jun; 26(17):2911-5. PubMed ID: 18539972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors.
    Sarris AH; Talpaz M; Deisseroth AB; Estrov Z
    Leukemia; 1996 May; 10(5):757-65. PubMed ID: 8656668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiparametric analysis of apoptotic and multi-drug resistance phenotypes according to the blast cell maturation stage in elderly patients with acute myeloid leukemia.
    Suárez L; Vidriales B; García-Laraña J; López A; Martínez R; Martín-Reina V; Tormo M; González-San Miguel JD; Lavilla E; García-Boyero R; Orfao A; San Miguel JF;
    Haematologica; 2001 Dec; 86(12):1287-95. PubMed ID: 11726321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leukemic stem cells show the way.
    Bonnet D
    Folia Histochem Cytobiol; 2005; 43(4):183-6. PubMed ID: 16382881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.